Erminia Massarelli

机构：The University of Texas at Tyler, City of Hope, The University of Texas Health Science Center at Tyler · ORCID：0000-0001-7798-7286

发表论文 294 篇 · 总被引 12312 次 · h-index 45

代表论文

• Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer (2025 · Journal of Clinical Oncology · 被引 89)
• Single-Agent Divarasib in Patients With KRAS G12C –Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study (2025 · Journal of Clinical Oncology · 被引 30)
• Osimertinib plus consolidative radiotherapy for advanced EGFR mutant non–small cell lung cancer: a multicentre, single-arm, phase 2 trial (2025 · EClinicalMedicine · 被引 16)
• Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy (2025 · Journal of Clinical Oncology · 被引 13)
• Current Development of Therapeutic Vaccines in Lung Cancer (2025 · Vaccines · 被引 11)
• OA14.06 Divarasib Single-Agent Long-Term Follow-up and Atezolizumab Combination Treatment in Patients with KRAS G12C-Positive NSCLC (2024 · Journal of Thoracic Oncology · 被引 7)